Plain-English translation of NCT05228262 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a research study for postmenopausal women who have been diagnosed with osteoporosis (weak bones) and are starting treatment. Researchers want to understand how bone loss medications affect not just your bones, but also your blood vessels, heart health, muscle strength, and overall well-being. The study will follow you over time as you take the medication to see how your body responds.
Osteoporosis medications are effective at strengthening bones, but doctors don't fully understand how these medications affect other parts of your body—like your blood vessels and muscles. This study aims to fill that gap and discover whether the treatment might have benefits (or risks) beyond bone health.
You likely qualify if…
You likely don't qualify if…
You will have six visits over the study period: one initial visit at the rheumatology department for diagnosis confirmation, and five follow-up visits at the research center where doctors will perform tests to measure your blood vessel function, heart health, muscle strength, bone changes, and quality of life. You may also be asked to provide blood samples and possibly genetic samples for research. All of this happens alongside your regular osteoporosis treatment as prescribed by your doctor.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Sponsor
University Hospital, Clermont-Ferrand
Enrollment target
~150 participants
Started
February 2022
Primary completion
February 2027
Age range
50 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in October 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lise LACLAUTRE
University Hospital, Clermont-Ferrand
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.